Can-Fite BioPharma Ltd. financial data

Symbol
CANF on NYSE
Location
Ramat Gan, Israel
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 14 Apr 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,983,181,793 shares 119%
Common Stock, Shares, Outstanding 3,967,407,393 shares 137%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $6,454,000 USD 37%
Cash, Cash Equivalents, and Short-term Investments $7,882,000 USD -11%
Assets, Current $7,624,000 USD 31%
Property, Plant and Equipment, Net $5,000 USD -84%
Operating Lease, Right-of-Use Asset $91,000 USD 47%
Assets $7,720,000 USD 30%
Employee-related Liabilities, Current $675,000 USD -2.7%
Accrued Liabilities, Current $301,000 USD 20%
Contract with Customer, Liability, Current $405,000 USD -36%
Liabilities, Current $2,120,000 USD 6.7%
Contract with Customer, Liability, Noncurrent $1,383,000 USD -3.6%
Operating Lease, Liability, Noncurrent $33,000 USD 57%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,127,000 USD 0%
Retained Earnings (Accumulated Deficit) $171,237,000 USD -5.4%
Stockholders' Equity Attributable to Parent $4,184,000 USD 69%
Liabilities and Equity $7,720,000 USD 30%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 20,000,000,000 shares 300%
Common Stock, Shares, Issued 3,967,407,393 shares 137%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6,454,000 USD 37%
Deferred Tax Assets, Valuation Allowance $28,060,000 USD 5.2%
Deferred Tax Assets, Gross $28,060,000 USD 5.2%
Operating Lease, Liability $104,000 USD 160%
Lessee, Operating Lease, Liability, to be Paid $133,000 USD 217%
Property, Plant and Equipment, Gross $79,000 USD -73%
Operating Lease, Liability, Current $57,000 USD 58%
Lessee, Operating Lease, Liability, to be Paid, Year Two $52,000 USD 271%
Lessee, Operating Lease, Liability, to be Paid, Year One $52,000 USD 108%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $29,000 USD 1350%
Lessee, Operating Lease, Liability, to be Paid, Year Three $29,000 USD 867%
Deferred Tax Assets, Operating Loss Carryforwards $26,998,000 USD 5.4%
Unrecognized Tax Benefits $0 USD
Additional Paid in Capital $163,790,000 USD 1.9%